3 Papers
K. Kamboj is an academic researcher from Post Graduate Institute of Medical Education and Research. The author has contributed to research in topics: Kidney disease & Medicine. The author has an hindex of 1, co-authored 3 publications.
Chat about Author
Papers
The Indian Chronic Kidney Disease (ICKD) study: baseline characteristics
Vivek Kumar,Ashok Kumar Yadav,Jasmine Sethi,Arpita Ghosh,Manisha Sahay,Narayan Prasad,Santosh Varughese,Sreejith Parameswaran,Natarajan Gopalakrishnan,Prabhjot Kaur,Gopesh K. Modi,K. Kamboj,Monica Kundu,Vivek Sood,Neeraj Inamdar,Ajay Jaryal,Sanjay Vikrant,Saurabh Nayak,Shivendra Singh,Sishir Gang,Seema Baid-Agrawal,Vivekanand Jha,Vivekanand Jha,Vivekanand Jha +23 more
TL;DR: Baseline characteristics of study population reveal differences as compared with other cohorts from high-income countries, and includes socio-demographic details, risk factors, disease characteristics and laboratory measurements.
65
Nonmedical Factors and Health-Related Quality of Life in CKD in India.
Gopesh K. Modi,Ashok Yadav,Arpita Ghosh,K. Kamboj,Prabhjot Kaur,Vivek Kumar,Shobhit Bhansali,Narayan Prasad,Manisha Sahay,Sreejith Parameswaran,Santosh Varughese,Sishir Gang,Shivendra Singh,D. Sircar,Natarajan Gopalakrishnan,Ajay Jaryal,Sanjay Vikrant,Seema Baid Agarwal,Vivekanand Jha,Vivekanand Jha,Vivekanand Jha +20 more
TL;DR: In this first of its kind analysis from India, predominantly socioeconomic factors were associated with quality of life scores in patients with CKD.
29
Prescription Practices in Patients With Mild to Moderate CKD in India.
Narayan Prasad,Ashok Kumar Yadav,Monica Kundu,Jasmin Sethi,Ajay Jaryal,D. Sircar,Gopesh K. Modi,K. Kamboj,Manisha Sahay,Natarajan Gopalakrishnan,Prabhjot Kaur,Sanjay Vikrant,Santosh Varughese,Seema Baid-Agrawal,Shivendra Singh,Sishir Gang,Sreejith Parameswaran,Vivek Kumar,Arpita Ghosh,Vivekanand Jha,Vivekanand Jha,Vivekanand Jha +21 more
TL;DR: In this paper, the authors describe the drug prescription practices in patients with mild to moderate chronic kidney disease (CKD) using baseline data from the Indian CKD (ICKD) cohort, and evaluate the appropriateness of medication use.
6